The Prescription Drugs (Pharmacies) market in Western Asia is experiencing steady growth and development, driven by various factors such as increasing customer preferences for convenience and accessibility, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Prescription Drugs (Pharmacies) market in Western Asia are shifting towards convenience and accessibility. Customers are increasingly seeking pharmacies that offer a wide range of prescription drugs and over-the-counter medications, as well as additional services such as home delivery and online ordering. This trend is driven by the busy lifestyles of customers who value convenience and time-saving options. Additionally, customers are becoming more informed about their healthcare needs and are actively seeking out pharmacies that provide personalized services and expert advice. Trends in the market are also contributing to the development of the Prescription Drugs (Pharmacies) market in Western Asia. One notable trend is the growing adoption of e-commerce in the pharmaceutical industry. Online pharmacies are becoming increasingly popular, allowing customers to conveniently purchase their prescription drugs and medications from the comfort of their own homes. This trend is particularly appealing to customers in Western Asia who may have limited access to physical pharmacies or face challenges in visiting them due to transportation or mobility issues. Another trend in the market is the increasing demand for generic drugs. Customers are becoming more price-conscious and are actively seeking affordable alternatives to brand-name prescription drugs. This trend is driven by the rising healthcare costs in Western Asia, as well as the growing availability and acceptance of generic drugs in the market. Pharmacies that offer a wide range of generic drugs are likely to attract a larger customer base and drive growth in the market. Local special circumstances also play a role in the development of the Prescription Drugs (Pharmacies) market in Western Asia. For example, some countries in the region have a high prevalence of chronic diseases such as diabetes and cardiovascular diseases. This creates a significant demand for prescription drugs and medications, leading to the growth of the pharmacy market. Additionally, the aging population in Western Asia is increasing the demand for healthcare services, including prescription drugs, as older individuals are more likely to require medication for chronic conditions. Underlying macroeconomic factors also contribute to the development of the Prescription Drugs (Pharmacies) market in Western Asia. Economic growth in the region has led to an increase in disposable income and healthcare expenditure, allowing customers to afford prescription drugs and medications. Furthermore, governments in Western Asia are investing in healthcare infrastructure and implementing policies to improve access to healthcare services, including pharmacies. These factors create a favorable environment for the growth and development of the Prescription Drugs (Pharmacies) market in Western Asia. Overall, the Prescription Drugs (Pharmacies) market in Western Asia is developing due to shifting customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The market is expected to continue growing as customers prioritize convenience and accessibility, online pharmacies gain popularity, and the demand for affordable prescription drugs increases.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
